Valuation: Flerie Invest AB

Market Cap 1.21B 123M 110M 101M 91.56M 171M 11.65B 174M 484M 6.13B 460M 451M 19.32B P/E 2024
-14.5x
P/E 2025 -3.86x
Enterprise Value 667M 67.89M 60.81M 55.93M 50.68M 94.73M 6.45B 96.5M 268M 3.39B 255M 249M 10.69B EV / Sales 2024
1,077x
EV / Sales 2025 945x
Free-Float
24.36%
Yield 2024 *
-
Yield 2025 -
1 day-3.14%
1 week-8.55%
Current month-14.72%
1 month-14.72%
3 months-31.19%
6 months-41.60%
Current year-57.58%
1 week 13
Extreme 13
15.3
1 month 13
Extreme 13
16.7
Current year 13
Extreme 13
33.25
1 year 13
Extreme 13
35.13
3 years 13
Extreme 13
49.88
5 years 13
Extreme 13
49.88
10 years 13
Extreme 13
49.88
Manager TitleAgeSince
Chief Executive Officer 48 2022-12-31
Director of Finance/CFO 54 2023-12-31
Chief Operating Officer 39 2023-12-31
Director TitleAgeSince
Director/Board Member 60 2022-12-31
Chairman 66 2022-12-31
Director/Board Member 72 2022-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/26 Free

Executive/Senior Manager

59,328 0.0745%
5/19/26 Don

Founder

-4,127,780 5.1829%
5/19/26 Free

Founder

4,284,798 5.3800%
Change 5-day change 1-year change 3-year change Capi.($)
-3.14%-8.55%-60.48% - 123M
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +1.24%+4.45%+35.88%+83.14% 426.21B
Weighted average by Cap. +1.19%+6.60%+50.88%+98.31%

Financials

2024 2025
Net sales 2.6M 265K 237K 218K 198K 369K 25.13M 376K 1.04M 13.22M 993K 972K 41.69M 2.5M 254K 228K 210K 190K 355K 24.16M 362K 1M 12.71M 955K 935K 40.08M
Net income -228M -23.21M -20.79M -19.12M -17.32M -32.38M -2.2B -32.99M -91.53M -1.16B -87.1M -85.25M -3.66B -757M -77.05M -69M -63.47M -57.51M -107M -7.32B -110M -304M -3.85B -289M -283M -12.14B
Net Debt -864M -87.98M -78.79M -72.48M -65.67M -123M -8.35B -125M -347M -4.39B -330M -323M -13.86B -538M -54.77M -49.06M -45.12M -40.89M -76.42M -5.2B -77.86M -216M -2.74B -206M -201M -8.63B
Projected Income Statement - Annual - Flerie Invest AB
Logo Flerie Invest AB
Flerie AB, formerly InDex Pharmaceuticals Holding AB, is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is an active long-term global biotech and pharmaceutical investor that managing a portfolio of companies in Europe, Israel, and the US. Flerie invests in companies across the entire value chain, providing exposure to opportunities across three segments: Product Development, Commercial Growth, and Limited Partnerships. The Product Development segment consists of early-stage biotech and pharma companies in product development. The Commercial Growth segment consists of companies that are already selling products or services and showcasing proof-of-concept with high growth and some that have already reached profitability. The Limited Partnerships segment provides benefits for the other two segments, including co-investment opportunities, and derisks Flerie’s investment portfolio.
Employees
8
Date Price Change Volume
26-10-30 SEK 13.90 -3.14% 44,134
26-10-29 SEK 14.35 +0.35% 141,612
26-10-28 SEK 14.30 -3.38% 203,160
26-10-27 SEK 14.80 -0.67% 32,200
26-10-26 SEK 14.90 -1.97% 67,671
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
13.90SEK
Average target price
22.00SEK
Spread / Average Target
+58.27%
  1. Stock Market
  2. Stocks
  3. FLERIE Stock